nodes	percent_of_prediction	percent_of_DWPC	metapath
Diltiazem—Skin hyperpigmentation—Carmustine—malignant glioma	0.0112	0.0201	CcSEcCtD
Diltiazem—Tooth disorder—Temozolomide—malignant glioma	0.00988	0.0179	CcSEcCtD
Diltiazem—Myopathy—Temozolomide—malignant glioma	0.00914	0.0165	CcSEcCtD
Diltiazem—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00851	0.0154	CcSEcCtD
Diltiazem—Otitis media—Temozolomide—malignant glioma	0.00823	0.0149	CcSEcCtD
Diltiazem—Petechiae—Temozolomide—malignant glioma	0.00779	0.0141	CcSEcCtD
Diltiazem—Liver injury—Temozolomide—malignant glioma	0.00762	0.0138	CcSEcCtD
Diltiazem—Accidental injury—Carmustine—malignant glioma	0.0075	0.0135	CcSEcCtD
Diltiazem—Thinking abnormal—Carmustine—malignant glioma	0.00725	0.0131	CcSEcCtD
Diltiazem—Gait disturbance—Carmustine—malignant glioma	0.0068	0.0123	CcSEcCtD
Diltiazem—Neck pain—Carmustine—malignant glioma	0.00671	0.0121	CcSEcCtD
Diltiazem—Injection site reaction—Carmustine—malignant glioma	0.0066	0.0119	CcSEcCtD
Diltiazem—Gait disturbance—Temozolomide—malignant glioma	0.00657	0.0119	CcSEcCtD
Diltiazem—Musculoskeletal pain—Temozolomide—malignant glioma	0.00649	0.0117	CcSEcCtD
Diltiazem—Vaginal inflammation—Temozolomide—malignant glioma	0.00641	0.0116	CcSEcCtD
Diltiazem—Neuropathy—Carmustine—malignant glioma	0.00623	0.0112	CcSEcCtD
Diltiazem—Vaginal infection—Temozolomide—malignant glioma	0.00605	0.0109	CcSEcCtD
Diltiazem—Neuropathy—Temozolomide—malignant glioma	0.00602	0.0109	CcSEcCtD
Diltiazem—Gynaecomastia—Carmustine—malignant glioma	0.00594	0.0107	CcSEcCtD
Diltiazem—Abnormal vision—Carmustine—malignant glioma	0.00579	0.0104	CcSEcCtD
Diltiazem—Mental disability—Carmustine—malignant glioma	0.00576	0.0104	CcSEcCtD
Diltiazem—Abnormal vision—Temozolomide—malignant glioma	0.00559	0.0101	CcSEcCtD
Diltiazem—Phlebitis—Carmustine—malignant glioma	0.00559	0.0101	CcSEcCtD
Diltiazem—Mental disability—Temozolomide—malignant glioma	0.00556	0.01	CcSEcCtD
Diltiazem—Swelling—Carmustine—malignant glioma	0.00546	0.00986	CcSEcCtD
Diltiazem—Ear pain—Temozolomide—malignant glioma	0.00545	0.00985	CcSEcCtD
Diltiazem—Injury—Carmustine—malignant glioma	0.00524	0.00946	CcSEcCtD
Diltiazem—Vascular purpura—Temozolomide—malignant glioma	0.0052	0.0094	CcSEcCtD
Diltiazem—Amnesia—Carmustine—malignant glioma	0.00513	0.00926	CcSEcCtD
Diltiazem—Nasal congestion—Temozolomide—malignant glioma	0.00511	0.00923	CcSEcCtD
Diltiazem—Amnesia—Temozolomide—malignant glioma	0.00495	0.00895	CcSEcCtD
Diltiazem—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00493	0.00891	CcSEcCtD
Diltiazem—Thirst—Temozolomide—malignant glioma	0.00489	0.00883	CcSEcCtD
Diltiazem—Purpura—Temozolomide—malignant glioma	0.00483	0.00872	CcSEcCtD
Diltiazem—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00482	0.0087	CcSEcCtD
Diltiazem—Diplopia—Carmustine—malignant glioma	0.00482	0.0087	CcSEcCtD
Diltiazem—Diplopia—Temozolomide—malignant glioma	0.00465	0.0084	CcSEcCtD
Diltiazem—Face oedema—Carmustine—malignant glioma	0.00465	0.0084	CcSEcCtD
Diltiazem—Affect lability—Temozolomide—malignant glioma	0.00458	0.00827	CcSEcCtD
Diltiazem—Face oedema—Temozolomide—malignant glioma	0.00449	0.00811	CcSEcCtD
Diltiazem—Mood swings—Temozolomide—malignant glioma	0.00441	0.00796	CcSEcCtD
Diltiazem—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00419	0.00757	CcSEcCtD
Diltiazem—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00419	0.00757	CcSEcCtD
Diltiazem—Abdominal distension—Temozolomide—malignant glioma	0.00405	0.00731	CcSEcCtD
Diltiazem—Bronchitis—Temozolomide—malignant glioma	0.00387	0.00699	CcSEcCtD
Diltiazem—Hyperglycaemia—Carmustine—malignant glioma	0.00375	0.00678	CcSEcCtD
Diltiazem—Pollakiuria—Temozolomide—malignant glioma	0.00372	0.00671	CcSEcCtD
Diltiazem—Erectile dysfunction—Temozolomide—malignant glioma	0.0037	0.00669	CcSEcCtD
Diltiazem—Photosensitivity reaction—Temozolomide—malignant glioma	0.00367	0.00663	CcSEcCtD
Diltiazem—Weight increased—Temozolomide—malignant glioma	0.00366	0.00661	CcSEcCtD
Diltiazem—Renal failure—Carmustine—malignant glioma	0.00365	0.00659	CcSEcCtD
Diltiazem—Neuropathy peripheral—Carmustine—malignant glioma	0.00364	0.00657	CcSEcCtD
Diltiazem—Hyperglycaemia—Temozolomide—malignant glioma	0.00363	0.00655	CcSEcCtD
Diltiazem—Urinary tract infection—Carmustine—malignant glioma	0.00361	0.00651	CcSEcCtD
Diltiazem—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00356	0.00642	CcSEcCtD
Diltiazem—Neuropathy peripheral—Temozolomide—malignant glioma	0.00352	0.00635	CcSEcCtD
Diltiazem—Urinary tract infection—Temozolomide—malignant glioma	0.00349	0.0063	CcSEcCtD
Diltiazem—Sinusitis—Temozolomide—malignant glioma	0.00336	0.00608	CcSEcCtD
Diltiazem—Hallucination—Carmustine—malignant glioma	0.00331	0.00599	CcSEcCtD
Diltiazem—Oedema peripheral—Carmustine—malignant glioma	0.00328	0.00593	CcSEcCtD
Diltiazem—Hepatitis—Temozolomide—malignant glioma	0.00322	0.00581	CcSEcCtD
Diltiazem—Visual impairment—Carmustine—malignant glioma	0.00321	0.0058	CcSEcCtD
Diltiazem—Hallucination—Temozolomide—malignant glioma	0.0032	0.00579	CcSEcCtD
Diltiazem—Pharyngitis—Temozolomide—malignant glioma	0.0032	0.00577	CcSEcCtD
Diltiazem—Urinary tract disorder—Temozolomide—malignant glioma	0.00318	0.00574	CcSEcCtD
Diltiazem—Oedema peripheral—Temozolomide—malignant glioma	0.00317	0.00573	CcSEcCtD
Diltiazem—Urethral disorder—Temozolomide—malignant glioma	0.00316	0.0057	CcSEcCtD
Diltiazem—Eye disorder—Carmustine—malignant glioma	0.00311	0.00562	CcSEcCtD
Diltiazem—Visual impairment—Temozolomide—malignant glioma	0.0031	0.0056	CcSEcCtD
Diltiazem—Flushing—Carmustine—malignant glioma	0.00309	0.00558	CcSEcCtD
Diltiazem—Erythema multiforme—Temozolomide—malignant glioma	0.00304	0.0055	CcSEcCtD
Diltiazem—Eye disorder—Temozolomide—malignant glioma	0.00301	0.00543	CcSEcCtD
Diltiazem—Tinnitus—Temozolomide—malignant glioma	0.003	0.00542	CcSEcCtD
Diltiazem—Flushing—Temozolomide—malignant glioma	0.00299	0.0054	CcSEcCtD
Diltiazem—Cardiac disorder—Temozolomide—malignant glioma	0.00299	0.0054	CcSEcCtD
Diltiazem—Arrhythmia—Carmustine—malignant glioma	0.00298	0.00537	CcSEcCtD
Diltiazem—Alopecia—Carmustine—malignant glioma	0.00294	0.00532	CcSEcCtD
Diltiazem—Angiopathy—Temozolomide—malignant glioma	0.00292	0.00528	CcSEcCtD
Diltiazem—Mediastinal disorder—Temozolomide—malignant glioma	0.0029	0.00524	CcSEcCtD
Diltiazem—Malnutrition—Carmustine—malignant glioma	0.0029	0.00524	CcSEcCtD
Diltiazem—Erythema—Carmustine—malignant glioma	0.0029	0.00524	CcSEcCtD
Diltiazem—Alopecia—Temozolomide—malignant glioma	0.00284	0.00514	CcSEcCtD
Diltiazem—Malnutrition—Temozolomide—malignant glioma	0.0028	0.00506	CcSEcCtD
Diltiazem—Erythema—Temozolomide—malignant glioma	0.0028	0.00506	CcSEcCtD
Diltiazem—Dysgeusia—Temozolomide—malignant glioma	0.00274	0.00496	CcSEcCtD
Diltiazem—Vision blurred—Carmustine—malignant glioma	0.00273	0.00494	CcSEcCtD
Diltiazem—Tremor—Carmustine—malignant glioma	0.00272	0.00491	CcSEcCtD
Diltiazem—Vision blurred—Temozolomide—malignant glioma	0.00264	0.00477	CcSEcCtD
Diltiazem—Tremor—Temozolomide—malignant glioma	0.00263	0.00474	CcSEcCtD
Diltiazem—Ill-defined disorder—Temozolomide—malignant glioma	0.0026	0.0047	CcSEcCtD
Diltiazem—Leukopenia—Carmustine—malignant glioma	0.0026	0.00469	CcSEcCtD
Diltiazem—Angioedema—Temozolomide—malignant glioma	0.00256	0.00462	CcSEcCtD
Diltiazem—Malaise—Temozolomide—malignant glioma	0.00253	0.00456	CcSEcCtD
Diltiazem—Vertigo—Temozolomide—malignant glioma	0.00252	0.00455	CcSEcCtD
Diltiazem—Leukopenia—Temozolomide—malignant glioma	0.00251	0.00453	CcSEcCtD
Diltiazem—Palpitations—Temozolomide—malignant glioma	0.00248	0.00447	CcSEcCtD
Diltiazem—Chest pain—Carmustine—malignant glioma	0.00247	0.00446	CcSEcCtD
Diltiazem—Myalgia—Carmustine—malignant glioma	0.00247	0.00446	CcSEcCtD
Diltiazem—Cough—Temozolomide—malignant glioma	0.00245	0.00442	CcSEcCtD
Diltiazem—Arthralgia—Temozolomide—malignant glioma	0.00239	0.00431	CcSEcCtD
Diltiazem—Myalgia—Temozolomide—malignant glioma	0.00239	0.00431	CcSEcCtD
Diltiazem—Oedema—Carmustine—malignant glioma	0.00237	0.00427	CcSEcCtD
Diltiazem—Discomfort—Temozolomide—malignant glioma	0.00236	0.00426	CcSEcCtD
Diltiazem—Infection—Carmustine—malignant glioma	0.00235	0.00425	CcSEcCtD
Diltiazem—Dry mouth—Temozolomide—malignant glioma	0.00233	0.00421	CcSEcCtD
Diltiazem—Thrombocytopenia—Carmustine—malignant glioma	0.00232	0.00419	CcSEcCtD
Diltiazem—Tachycardia—Carmustine—malignant glioma	0.00231	0.00417	CcSEcCtD
Diltiazem—Oedema—Temozolomide—malignant glioma	0.00229	0.00413	CcSEcCtD
Diltiazem—Infection—Temozolomide—malignant glioma	0.00227	0.0041	CcSEcCtD
Diltiazem—Anorexia—Carmustine—malignant glioma	0.00226	0.00407	CcSEcCtD
Diltiazem—Nervous system disorder—Temozolomide—malignant glioma	0.00224	0.00405	CcSEcCtD
Diltiazem—Thrombocytopenia—Temozolomide—malignant glioma	0.00224	0.00404	CcSEcCtD
Diltiazem—Hypotension—Carmustine—malignant glioma	0.00221	0.00399	CcSEcCtD
Diltiazem—Hyperhidrosis—Temozolomide—malignant glioma	0.00221	0.00399	CcSEcCtD
Diltiazem—Anorexia—Temozolomide—malignant glioma	0.00218	0.00394	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00216	0.00389	CcSEcCtD
Diltiazem—Insomnia—Carmustine—malignant glioma	0.00214	0.00387	CcSEcCtD
Diltiazem—Paraesthesia—Carmustine—malignant glioma	0.00213	0.00384	CcSEcCtD
Diltiazem—Dyspnoea—Carmustine—malignant glioma	0.00211	0.00381	CcSEcCtD
Diltiazem—Somnolence—Carmustine—malignant glioma	0.0021	0.0038	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00208	0.00376	CcSEcCtD
Diltiazem—Insomnia—Temozolomide—malignant glioma	0.00207	0.00374	CcSEcCtD
Diltiazem—Decreased appetite—Carmustine—malignant glioma	0.00206	0.00372	CcSEcCtD
Diltiazem—Paraesthesia—Temozolomide—malignant glioma	0.00205	0.00371	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Carmustine—malignant glioma	0.00204	0.00369	CcSEcCtD
Diltiazem—Dyspnoea—Temozolomide—malignant glioma	0.00204	0.00368	CcSEcCtD
Diltiazem—Somnolence—Temozolomide—malignant glioma	0.00203	0.00367	CcSEcCtD
Diltiazem—Pain—Carmustine—malignant glioma	0.00202	0.00366	CcSEcCtD
Diltiazem—Constipation—Carmustine—malignant glioma	0.00202	0.00366	CcSEcCtD
Diltiazem—Dyspepsia—Temozolomide—malignant glioma	0.00201	0.00364	CcSEcCtD
Diltiazem—Decreased appetite—Temozolomide—malignant glioma	0.00199	0.00359	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00197	0.00357	CcSEcCtD
Diltiazem—Fatigue—Temozolomide—malignant glioma	0.00197	0.00356	CcSEcCtD
Diltiazem—Pain—Temozolomide—malignant glioma	0.00196	0.00353	CcSEcCtD
Diltiazem—Constipation—Temozolomide—malignant glioma	0.00196	0.00353	CcSEcCtD
Diltiazem—Feeling abnormal—Carmustine—malignant glioma	0.00195	0.00352	CcSEcCtD
Diltiazem—Feeling abnormal—Temozolomide—malignant glioma	0.00188	0.0034	CcSEcCtD
Diltiazem—Body temperature increased—Carmustine—malignant glioma	0.00187	0.00338	CcSEcCtD
Diltiazem—Abdominal pain—Carmustine—malignant glioma	0.00187	0.00338	CcSEcCtD
Diltiazem—Urticaria—Temozolomide—malignant glioma	0.00182	0.00328	CcSEcCtD
Diltiazem—Abdominal pain—Temozolomide—malignant glioma	0.00181	0.00327	CcSEcCtD
Diltiazem—Body temperature increased—Temozolomide—malignant glioma	0.00181	0.00327	CcSEcCtD
Diltiazem—Hypersensitivity—Carmustine—malignant glioma	0.00174	0.00315	CcSEcCtD
Diltiazem—Asthenia—Carmustine—malignant glioma	0.0017	0.00307	CcSEcCtD
Diltiazem—Hypersensitivity—Temozolomide—malignant glioma	0.00169	0.00304	CcSEcCtD
Diltiazem—Asthenia—Temozolomide—malignant glioma	0.00164	0.00296	CcSEcCtD
Diltiazem—Diarrhoea—Carmustine—malignant glioma	0.00162	0.00292	CcSEcCtD
Diltiazem—Pruritus—Temozolomide—malignant glioma	0.00162	0.00292	CcSEcCtD
Diltiazem—Dizziness—Carmustine—malignant glioma	0.00157	0.00283	CcSEcCtD
Diltiazem—Diarrhoea—Temozolomide—malignant glioma	0.00157	0.00283	CcSEcCtD
Diltiazem—Dizziness—Temozolomide—malignant glioma	0.00151	0.00273	CcSEcCtD
Diltiazem—Vomiting—Carmustine—malignant glioma	0.0015	0.00272	CcSEcCtD
Diltiazem—Rash—Carmustine—malignant glioma	0.00149	0.0027	CcSEcCtD
Diltiazem—Dermatitis—Carmustine—malignant glioma	0.00149	0.00269	CcSEcCtD
Diltiazem—Headache—Carmustine—malignant glioma	0.00148	0.00268	CcSEcCtD
Diltiazem—Vomiting—Temozolomide—malignant glioma	0.00145	0.00263	CcSEcCtD
Diltiazem—Rash—Temozolomide—malignant glioma	0.00144	0.0026	CcSEcCtD
Diltiazem—Dermatitis—Temozolomide—malignant glioma	0.00144	0.0026	CcSEcCtD
Diltiazem—Headache—Temozolomide—malignant glioma	0.00143	0.00259	CcSEcCtD
Diltiazem—Nausea—Carmustine—malignant glioma	0.00141	0.00254	CcSEcCtD
Diltiazem—Nausea—Temozolomide—malignant glioma	0.00136	0.00245	CcSEcCtD
Diltiazem—Triflupromazine—BCHE—malignant glioma	0.00116	0.445	CrCbGaD
Diltiazem—Promethazine—CYP2B6—malignant glioma	0.000883	0.34	CrCbGaD
Diltiazem—Chlorpromazine—BCHE—malignant glioma	0.000558	0.215	CrCbGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000155	0.000349	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—CYP2C18—malignant glioma	0.000155	0.000348	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000153	0.000345	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—COX8A—malignant glioma	0.000151	0.000341	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—COX8A—malignant glioma	0.00015	0.000338	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—BCAN—malignant glioma	0.000147	0.000332	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000147	0.000331	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000146	0.000329	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—VEGFA—malignant glioma	0.000145	0.000327	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—STAT3—malignant glioma	0.000144	0.000324	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—GSTP1—malignant glioma	0.000142	0.000319	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—ASMT—malignant glioma	0.00014	0.000315	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000139	0.000312	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—CAT—malignant glioma	0.000138	0.00031	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—IDH2—malignant glioma	0.000137	0.000309	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000137	0.000308	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000137	0.000308	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—ASMT—malignant glioma	0.000137	0.000308	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000136	0.000308	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000136	0.000307	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000135	0.000304	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000134	0.000302	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000132	0.000297	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—BCAN—malignant glioma	0.000131	0.000296	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—EGFR—malignant glioma	0.000131	0.000295	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—NCOR1—malignant glioma	0.00013	0.000293	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—AKT1—malignant glioma	0.00013	0.000293	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CYP2B6—malignant glioma	0.000129	0.000291	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—ASMT—malignant glioma	0.000129	0.00029	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—BCAN—malignant glioma	0.000128	0.000289	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—ASMT—malignant glioma	0.000128	0.000287	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000125	0.000282	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—GSTT1—malignant glioma	0.000125	0.000282	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000125	0.000281	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—TNF—malignant glioma	0.000124	0.000281	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—KRAS—malignant glioma	0.000123	0.000278	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000122	0.000276	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—BCAN—malignant glioma	0.000121	0.000273	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—BCAN—malignant glioma	0.00012	0.00027	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000119	0.000269	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—IDH2—malignant glioma	0.000119	0.000268	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—IDH1—malignant glioma	0.000118	0.000266	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PTGS1—malignant glioma	0.000117	0.000264	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000115	0.000259	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—SPHK1—malignant glioma	0.000114	0.000257	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000112	0.000252	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CYP2C18—malignant glioma	0.000112	0.000252	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CYP2B6—malignant glioma	0.000112	0.000252	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—BCHE—malignant glioma	0.000109	0.000246	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—SLC5A5—malignant glioma	0.000108	0.000243	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—CAV1—malignant glioma	0.000106	0.000239	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—IDH2—malignant glioma	0.000106	0.000239	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000104	0.000234	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—IDH2—malignant glioma	0.000103	0.000233	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—IDH1—malignant glioma	0.000102	0.00023	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	9.99e-05	0.000225	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CYP2B6—malignant glioma	9.97e-05	0.000225	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—COX8A—malignant glioma	9.89e-05	0.000223	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—SPHK1—malignant glioma	9.88e-05	0.000223	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—IDH2—malignant glioma	9.75e-05	0.00022	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CYP2B6—malignant glioma	9.73e-05	0.000219	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CYP2C18—malignant glioma	9.68e-05	0.000218	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—IDH2—malignant glioma	9.66e-05	0.000218	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PIK3CG—malignant glioma	9.66e-05	0.000218	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	9.54e-05	0.000215	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	9.34e-05	0.00021	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PPARG—malignant glioma	9.32e-05	0.00021	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—AKT1—malignant glioma	9.27e-05	0.000209	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CYP2B6—malignant glioma	9.17e-05	0.000207	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.13e-05	0.000206	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—IDH1—malignant glioma	9.11e-05	0.000205	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	9.11e-05	0.000205	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CYP2B6—malignant glioma	9.09e-05	0.000205	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—GSTT1—malignant glioma	9.04e-05	0.000204	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—IDH1—malignant glioma	8.9e-05	0.000201	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	8.89e-05	0.0002	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	8.82e-05	0.000199	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—SPHK1—malignant glioma	8.82e-05	0.000199	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—GSTP1—malignant glioma	8.67e-05	0.000195	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CYP2C18—malignant glioma	8.64e-05	0.000195	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—SPHK1—malignant glioma	8.61e-05	0.000194	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PIK3CD—malignant glioma	8.49e-05	0.000191	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PTGS1—malignant glioma	8.47e-05	0.000191	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—CAT—malignant glioma	8.43e-05	0.00019	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CYP2C18—malignant glioma	8.43e-05	0.00019	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—ASMT—malignant glioma	8.41e-05	0.00019	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—IDH1—malignant glioma	8.38e-05	0.000189	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.31e-05	0.000187	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—IDH1—malignant glioma	8.31e-05	0.000187	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.15e-05	0.000184	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—SPHK1—malignant glioma	8.11e-05	0.000183	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	8.1e-05	0.000183	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—SPHK1—malignant glioma	8.04e-05	0.000181	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.02e-05	0.000181	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—NCOR1—malignant glioma	7.96e-05	0.00018	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CYP2C18—malignant glioma	7.95e-05	0.000179	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—BCAN—malignant glioma	7.91e-05	0.000178	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CYP2C18—malignant glioma	7.88e-05	0.000178	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—BCHE—malignant glioma	7.87e-05	0.000177	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	7.84e-05	0.000177	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—GSTT1—malignant glioma	7.83e-05	0.000176	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—SLC5A5—malignant glioma	7.78e-05	0.000175	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.43e-05	0.000167	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.42e-05	0.000167	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PIK3CB—malignant glioma	7.4e-05	0.000167	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PTGS1—malignant glioma	7.34e-05	0.000165	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PTGS2—malignant glioma	7.33e-05	0.000165	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.31e-05	0.000165	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.16e-05	0.000161	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—GSTT1—malignant glioma	6.99e-05	0.000158	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—GSTT1—malignant glioma	6.82e-05	0.000154	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—BCHE—malignant glioma	6.82e-05	0.000154	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.77e-05	0.000153	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—SLC5A5—malignant glioma	6.74e-05	0.000152	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	6.62e-05	0.000149	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PTGS1—malignant glioma	6.55e-05	0.000148	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.53e-05	0.000147	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.52e-05	0.000147	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—CAV1—malignant glioma	6.49e-05	0.000146	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—GSTT1—malignant glioma	6.43e-05	0.000145	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PTEN—malignant glioma	6.39e-05	0.000144	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PTGS1—malignant glioma	6.39e-05	0.000144	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—IDH2—malignant glioma	6.37e-05	0.000144	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—GSTT1—malignant glioma	6.37e-05	0.000144	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.37e-05	0.000144	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.31e-05	0.000142	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—GSTP1—malignant glioma	6.27e-05	0.000141	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CAT—malignant glioma	6.1e-05	0.000137	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—BCHE—malignant glioma	6.09e-05	0.000137	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PTGS1—malignant glioma	6.02e-05	0.000136	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—SLC5A5—malignant glioma	6.01e-05	0.000136	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CYP2B6—malignant glioma	5.99e-05	0.000135	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PTGS1—malignant glioma	5.97e-05	0.000135	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.95e-05	0.000134	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—BCHE—malignant glioma	5.94e-05	0.000134	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PIK3CG—malignant glioma	5.91e-05	0.000133	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—SLC5A5—malignant glioma	5.87e-05	0.000132	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—NCOR1—malignant glioma	5.76e-05	0.00013	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PPARG—malignant glioma	5.71e-05	0.000129	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.69e-05	0.000128	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.63e-05	0.000127	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—BCHE—malignant glioma	5.6e-05	0.000126	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—BCHE—malignant glioma	5.55e-05	0.000125	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—SLC5A5—malignant glioma	5.53e-05	0.000125	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.51e-05	0.000124	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—SLC5A5—malignant glioma	5.48e-05	0.000124	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—IDH1—malignant glioma	5.48e-05	0.000124	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—GSTP1—malignant glioma	5.43e-05	0.000122	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	5.41e-05	0.000122	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—SPHK1—malignant glioma	5.3e-05	0.00012	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CAT—malignant glioma	5.28e-05	0.000119	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PIK3CD—malignant glioma	5.2e-05	0.000117	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.2e-05	0.000117	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.19e-05	0.000117	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.14e-05	0.000116	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—NCOR1—malignant glioma	4.99e-05	0.000112	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.91e-05	0.000111	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—GSTP1—malignant glioma	4.84e-05	0.000109	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—GSTP1—malignant glioma	4.73e-05	0.000107	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CAT—malignant glioma	4.71e-05	0.000106	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CAV1—malignant glioma	4.69e-05	0.000106	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CAT—malignant glioma	4.6e-05	0.000104	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PIK3CB—malignant glioma	4.53e-05	0.000102	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PIK3CA—malignant glioma	4.51e-05	0.000102	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PTGS2—malignant glioma	4.49e-05	0.000101	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.48e-05	0.000101	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—GSTP1—malignant glioma	4.45e-05	0.0001	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—NCOR1—malignant glioma	4.45e-05	0.0001	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—GSTP1—malignant glioma	4.42e-05	9.95e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—NCOR1—malignant glioma	4.34e-05	9.79e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CAT—malignant glioma	4.34e-05	9.77e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CAT—malignant glioma	4.3e-05	9.69e-05	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PIK3CG—malignant glioma	4.27e-05	9.64e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—GSTT1—malignant glioma	4.2e-05	9.47e-05	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PPARG—malignant glioma	4.13e-05	9.3e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—NCOR1—malignant glioma	4.09e-05	9.23e-05	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CAV1—malignant glioma	4.07e-05	9.16e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—NCOR1—malignant glioma	4.06e-05	9.15e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PTGS1—malignant glioma	3.94e-05	8.88e-05	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PTEN—malignant glioma	3.92e-05	8.83e-05	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.88e-05	8.75e-05	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PIK3CD—malignant glioma	3.76e-05	8.47e-05	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PIK3CG—malignant glioma	3.7e-05	8.35e-05	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—AKT1—malignant glioma	3.69e-05	8.31e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—BCHE—malignant glioma	3.66e-05	8.25e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CAV1—malignant glioma	3.63e-05	8.18e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.62e-05	8.15e-05	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PPARG—malignant glioma	3.57e-05	8.05e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CAV1—malignant glioma	3.54e-05	7.98e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.47e-05	7.81e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CAV1—malignant glioma	3.34e-05	7.52e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CAV1—malignant glioma	3.31e-05	7.46e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.31e-05	7.45e-05	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PIK3CB—malignant glioma	3.28e-05	7.38e-05	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PIK3CD—malignant glioma	3.26e-05	7.34e-05	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PTGS2—malignant glioma	3.25e-05	7.32e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PIK3CG—malignant glioma	3.23e-05	7.27e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PPARG—malignant glioma	3.19e-05	7.19e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.16e-05	7.12e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PPARG—malignant glioma	3.11e-05	7.02e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.04e-05	6.85e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.01e-05	6.79e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PPARG—malignant glioma	2.93e-05	6.61e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—GSTP1—malignant glioma	2.91e-05	6.56e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PPARG—malignant glioma	2.91e-05	6.56e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PIK3CD—malignant glioma	2.91e-05	6.55e-05	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PIK3CB—malignant glioma	2.84e-05	6.39e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PIK3CD—malignant glioma	2.84e-05	6.39e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CAT—malignant glioma	2.83e-05	6.39e-05	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PTEN—malignant glioma	2.83e-05	6.38e-05	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PTGS2—malignant glioma	2.81e-05	6.34e-05	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PIK3CA—malignant glioma	2.76e-05	6.23e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—NCOR1—malignant glioma	2.68e-05	6.03e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.67e-05	6.02e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.65e-05	5.97e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.53e-05	5.71e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PTGS2—malignant glioma	2.51e-05	5.66e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PIK3CB—malignant glioma	2.47e-05	5.57e-05	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PTEN—malignant glioma	2.45e-05	5.53e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PTGS2—malignant glioma	2.45e-05	5.52e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.33e-05	5.25e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.31e-05	5.2e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PTGS2—malignant glioma	2.31e-05	5.2e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PTGS2—malignant glioma	2.29e-05	5.16e-05	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—AKT1—malignant glioma	2.26e-05	5.09e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PTEN—malignant glioma	2.19e-05	4.93e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CAV1—malignant glioma	2.18e-05	4.92e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PTEN—malignant glioma	2.14e-05	4.81e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PTEN—malignant glioma	2.01e-05	4.54e-05	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PIK3CA—malignant glioma	2e-05	4.5e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PTEN—malignant glioma	2e-05	4.5e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.99e-05	4.48e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PPARG—malignant glioma	1.92e-05	4.32e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.75e-05	3.94e-05	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.73e-05	3.9e-05	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—AKT1—malignant glioma	1.63e-05	3.68e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.54e-05	3.48e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.52e-05	3.43e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PTGS2—malignant glioma	1.51e-05	3.4e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PIK3CA—malignant glioma	1.51e-05	3.4e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.42e-05	3.2e-05	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—AKT1—malignant glioma	1.41e-05	3.18e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.41e-05	3.17e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PTEN—malignant glioma	1.32e-05	2.97e-05	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—AKT1—malignant glioma	1.26e-05	2.84e-05	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—AKT1—malignant glioma	1.23e-05	2.77e-05	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—AKT1—malignant glioma	1.16e-05	2.61e-05	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—AKT1—malignant glioma	1.15e-05	2.59e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PIK3CA—malignant glioma	9.28e-06	2.09e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—AKT1—malignant glioma	7.58e-06	1.71e-05	CbGpPWpGaD
